Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Colomb

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Molecular Immunology|July 1, 1991
Covalent binding of non-proteolysed C3 to Jurkat T cellsC D Barro, C L Villiers, M G Colomb
Clinical and Experimental Immunology|February 1, 1994
IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patientsJ Arvieux, B Roussel, D Ponard, et al.
The Biochemical Journal|July 15, 1989
Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937C M Maison, C L Villiers, M G Colomb
Biochimica Et Biophysica Acta|April 11, 1980
Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1sR B Sim, G J Arlaud, M G Colomb
European Journal of Biochemistry|April 16, 1984
Diamine-induced dissociation of the first component of human complement, C1C L Villiers, G J Arlaud, M G Colomb
Infection and Immunity|December 1, 1993
Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteriaJ Croize, J Arvieux, P Berche, et al.
Bioscience Reports|October 1, 1985
C1r serine proteinase of human complement: a case of intramolecular autolytic activationG J Arlaud, M G Colomb, C L Villiers
FEBS Letters|July 3, 1970
35S-Atractyloside binding affinity to the inner mitochondrial membraneP V. Vignais, P M. Vignais, M G. Colomb
FEBS Letters|November 26, 1999
Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitorC Drouet, L Bouillet, F Csopaki, et al.
Complement (Basel, Switzerland)|January 1, 1984
Structure and activation of C1: current conceptsM G Colomb, G J Arlaud, C L Villiers
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Molecular Immunology|July 1, 1991
Covalent binding of non-proteolysed C3 to Jurkat T cellsC D Barro, C L Villiers, M G Colomb
Clinical and Experimental Immunology|February 1, 1994
IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patientsJ Arvieux, B Roussel, D Ponard, et al.
The Biochemical Journal|July 15, 1989
Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937C M Maison, C L Villiers, M G Colomb
Biochimica Et Biophysica Acta|April 11, 1980
Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1sR B Sim, G J Arlaud, M G Colomb
European Journal of Biochemistry|April 16, 1984
Diamine-induced dissociation of the first component of human complement, C1C L Villiers, G J Arlaud, M G Colomb
Infection and Immunity|December 1, 1993
Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteriaJ Croize, J Arvieux, P Berche, et al.
Bioscience Reports|October 1, 1985
C1r serine proteinase of human complement: a case of intramolecular autolytic activationG J Arlaud, M G Colomb, C L Villiers
FEBS Letters|July 3, 1970
35S-Atractyloside binding affinity to the inner mitochondrial membraneP V. Vignais, P M. Vignais, M G. Colomb
FEBS Letters|November 26, 1999
Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitorC Drouet, L Bouillet, F Csopaki, et al.
Complement (Basel, Switzerland)|January 1, 1984
Structure and activation of C1: current conceptsM G Colomb, G J Arlaud, C L Villiers
Pageof 10